After mulling over competing offers from both Pfizer and Novo Nordisk, Metsera has decided to go with the former’s $10bn ...

Pfizer Inc. (NYSE:PFE) strengthens its global pharmaceutical leadership and research presence in the S&P 500 Index.

Pfizer raised its full-year profit forecast for the second consecutive quarter and reported a higher-than-expected ...

Pfizer on Tuesday raised its full-year profit forecast for the second quarter in a row as robust demand for its blockbuster ...

How many companies will be left standing once consolidation hits the AI in healthcare sector? Which pharma companies are ...

The firm had decreased Q3 sales for precision oncology drugs including Ibrance, Tukysa, and Bosulif, but sales increased for ...

Pfizer, we imagine, wasn't too happy about the shout-out its Viagra product got yesterday when International Criminal Court prosecutor Luis Moreno-Ocampo announced, as part of his investigation into ...

The Most Favored Nation (MFN) executive order aims to align US drug prices with those in other wealthy nations, involving a deal with Pfizer and a new website, TrumpRx. Pfizer's agreement includes a 3 ...

Novo Nordisk is raising the stakes in its push to outbid rival Pfizer for the development-stage drugmaker Metsera. Metsera ...